🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Artificial Intelligence (AI)-Enhanced Pretreatment Peer-review Process to Improve Patient Safety in Radiation Oncology

RecruitingNAAges 18 Years - anyAllUNC Lineberger Comprehensive Cancer Center
NCT07463833 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This prospective study will test artificial intelligence (AI) and machine learning (ML) decision support tools. This tool is designed to help doctors, physicists and other staff during pre-treatment peer review, a step where treatment plans are checked before a patient begins care. The system highlights summaries showing how different providers may vary in their treatment planning (provider-variability summaries) and points out the best signals or warning signs to look for (optimal cues). By drawing attention to these patterns and cues, the tool aims to help reviewers spot possible treatment-planning mistakes earlier, reduce the chance of errors, and improve overall patient safety.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
In order to participate in this study a subject must meet all of the eligibility criteria outlined below. Inclusion Criteria: Providers only * ≥18 years * Peer-review attendees at participating clinics Patients only * ≥18 years * All patients with prostate cancer radiation therapy cases treated at participating sites (no intervention delivered to patients) Exclusion Criteria: Providers only • Providers unwilling/unable to comply with study procedures; sites unable to implement the workflow or provide required outcomes. Patients and Providers • Has dementia, altered mental status, or any psychiatric or co-morbid condition prohibiting the understanding or rendering of informed consent
💊

What it tests

  • The Artificial Intelligence (AI)/ Machine Learning (ML) contribution to treatment planning
📍

Where

1 site
University of North Carolina at Chapel Hill, Department of Radiation Oncology
Chapel Hill, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy